Veterinary Oncology Market, by Animal Type (Companion Animal (Equine, Canine, and Feline), and Livestock Animal), by Therapy Type (Chemotherapy, Combination Therapy, Immunotherapy, and Targeted Therapy), by Mode of Administration (Oral and Intravenous), by Application (Canine Lymphoma, Osteosarcoma (OSA), Mast Cell Cancer, Melanoma, and Multiple Myeloma), by Distribution Channel (Hospital Pharmacies, Government Agencies, and Retail Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2026

  • Published On : Aug 2019 |
  • Pages : 225 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Veterinary Oncology Market– Insights

Veterinary cancer therapies aim to permanently eradicate the cancerous cells prevalent in pets. The veterinarian recommends specific treatments such as targeted therapy and combination therapy or chemotherapy depending on the type of cancer, stage, and nature of the cancer. The ongoing research activities undertaken by researchers for the development of novel formulations and therapies is expected to accelerate the global veterinary oncology market growth. For instance, in 2015 researchers at the University of Veterinary Medicine Vienna are exploring the molecular basis of cancer progression in canine cell lines. The research states that the modern cancer therapy can be revolutionized with the introduction of targeted therapies.

The global veterinary oncology market size was valued at US$ 401.8 million in 2018, and is expected to witness a CAGR of 10.9% over the forecast period (2019–2026).

Global Veterinary Oncology Market Share (%) Analysis, By Animal Type, 2018

Veterinary Oncology  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Increasing R&D initiatives and veterinary healthcare expenditure for cancer management is expected to drive growth of the global veterinary oncology market

Increasing number of research grants to launch various anti-cancer therapies for veterinary cancer treatment is expected to be a major factor driving growth of the veterinary oncology market during the forecast period. For instance, in 2017, Animal Cancer Foundation (ACF) received a US$ 1 million grant from the Blue Buffalo Foundation to support comparative oncology research to study similarities between naturally occurring cancers in people and pets and find effective treatment for both species.

Growing expenditure on animal healthcare due to increasing pet healthcare spending by pet owners, especially in the developed economies is another major factor driving the veterinary oncology market growth. For instance, according to the American Pet Products Association report released in March 2018, the overall spending in the U.S. veterinary care increased by 4.1% between 2016 and 2017, from US$ 66.75 billion to US$ 69.51 billion which is expected to bring development in animal treatment.

Global Veterinary Oncology Market- Restraints

High cost associated with chemotherapies, immunotherapies, and targeted therapies are major factors restraining the veterinary oncology market growth. For instance, according to a study conducted by the University of Wisconsin, 2015, the initial veterinary cancer diagnosis costs US$ 1,000 – US$ 2,000 while a standard course of chemotherapy costs US$ 3,000– US$ 5,000, depending on the type and severity of cancer.

Global Veterinary Oncology Market- Regional Insights

On the basis of region, the global veterinary oncology market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global veterinary oncology market during the forecast period. This is owing to focus of key market players in the region on adopting strategies such as partnership and acquisitions in order to expand their product portfolio. For instance, in April 2019, Elanco Animal Health signed an agreement to acquire Aratana Therapeutics, a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats in the U.S.

Asia Pacific is expected to witness a rapid growth in the global veterinary oncology market during the forecast period, owing to the presence of various veterinary foundations focusing on veterinary cancer research. For example, The Australian Animal Cancer Foundation, Australia supports scientific research on veterinary cancer and seeks funds from government and private organizations. The foundation also supports Australian Comparative Oncology Consortium, consisting of Australian veterinary oncology specialists who collaborate to develop novel therapies.

Moreover, high prevalence of cancer in dogs is also expected to boost the market growth in the region. For instance, according to the Australia Canine Center, 2014, cancer affects 1 in every 3 dogs during their lifetime, in Australia.

Global Veterinary Oncology Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2026

Veterinary Oncology  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Global Veterinary Oncology Market- Competitive Landscape

Key players operating in the global veterinary oncology market include, Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., and Rhizen Pharmaceutical SA.

Veterinary oncology is subspecialty of veterinary medicine that deals with the diagnosis and treatment of cancer in animals. With emerging technologies, the use of biotechnology products in veterinary medicines is increasing. Despite the costs that many times accompany the development of novel biotechnological products, recombinant virus vector vaccines, recombinant proteins such as bioactive cytokines and immunotherapeutic allergens, therapeutic antibodies, and oncolytic viruses are the result of advancements in biotechnology for veterinary medicines. The benefits associated with using biotechnology products are large-scale production, reduced costs, long-term action, and multiple antigen vaccines.

Market Dynamics

Increasing prevalence of veterinary cancer is expected to boost the global veterinary oncology market growth during the forecast period. For instance, according to the Veterinary Cancer Society, in 2016, cancer is the leading cause of death in 47% of dogs diagnosed with cancer over the age of 10 years; and 32% of cats, where Feline Leukaemia Virus (FeLV) is one of the leading cause of lymphoma in cats. Moreover, according to the Animal Cancer Foundation in 2015, around 6 million new cancer cases in dogs and cats are recorded, annually, in the U.S., of which one-third of all tumors in dogs are skin tumors, while around 20% are mast cell tumors.

However, adverse effects associated with chemotherapies, immunotherapies, and targeted therapies such as diarrhoea, anorexia, decreased appetite, lethargy, neutropenia, emesis, lameness, severe weight loss, and musculoskeletal disorder are major factors restraining the veterinary oncology market growth.

Key features of the study:

  • This report provides in-depth analysis of the global veterinary oncology market, market size (US$ Mn), and compound annual growth rate (CAGR %) during the forecast period: 2019 – 2026, considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players operating in this market
  • It profiles key players in the global veterinary oncology market based on the following parameters–company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., and Rhizen Pharmaceutical SA
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global veterinary oncology market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for global veterinary oncology market, research and consulting firms, new entrants, and financial analysts

 Detailed Segmentation:

  • Global Veterinary Oncology Market, By Animal Type:
    • Companion Animal
      • Equine
      • Canine
      • Feline
    • Livestock Animal
  • Global Veterinary Oncology Market, By Therapy Type:
    • Chemotherapy
    • Combination Therapy
    • Immunotherapy
    • Targeted Therapy
  • Global Veterinary Oncology Market, By Mode of Administration:
    • Oral
    • Intravenous
  • Global Veterinary Oncology Market, By Application:
    • Canine Lymphoma
    • Osteosarcoma (OSA)
    • Mast Cell Cancer
    • Melanoma
    • Multiple Myeloma
  • Global Veterinary Oncology Market, By Distribution Channel:
    • Hospital Pharmacies
    • Government Agencies
    • Retail Pharmacies
  • Global Veterinary Oncology Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Animal Type:
        • Companion Animal
          • Equine
          • Canine
          • Feline
        • Livestock Animal
      • By Therapy Type:
        • Chemotherapy
        • Combination Therapy
        • Immunotherapy
        • Targeted Therapy
      • By Mode of Administration:
        • Oral
        • Intravenous
      • By Application:
        • Canine Lymphoma
        • Osteosarcoma (OSA)
        • Mast Cell Cancer
        • Melanoma
        • Multiple Myeloma
      • By Distribution Channel:
        • Hospital Pharmacies
        • Government Agencies
        • Retail Pharmacies
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Animal Type:
        • Companion Animal
          • Equine
          • Canine
          • Feline
        • Livestock Animal
      • By Therapy Type:
        • Chemotherapy
        • Combination Therapy
        • Immunotherapy
        • Targeted Therapy
      • By Mode of Administration:
        • Oral
        • Intravenous
      • By Application:
        • Canine Lymphoma
        • Osteosarcoma (OSA)
        • Mast Cell Cancer
        • Melanoma
        • Multiple Myeloma
      • By Distribution Channel:
        • Hospital Pharmacies
        • Government Agencies
        • Retail Pharmacies
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Animal Type:
        • Companion Animal
          • Equine
          • Canine
          • Feline
        • Livestock Animal
      • By Therapy Type:
        • Chemotherapy
        • Combination Therapy
        • Immunotherapy
        • Targeted Therapy
      • By Mode of Administration:
        • Oral
        • Intravenous
      • By Application:
        • Canine Lymphoma
        • Osteosarcoma (OSA)
        • Mast Cell Cancer
        • Melanoma
        • Multiple Myeloma
      • By Distribution Channel:
        • Hospital Pharmacies
        • Government Agencies
        • Retail Pharmacies
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Animal Type:
        • Companion Animal
          • Equine
          • Canine
          • Feline
        • Livestock Animal
      • By Therapy Type:
        • Chemotherapy
        • Combination Therapy
        • Immunotherapy
        • Targeted Therapy
      • By Mode of Administration:
        • Oral
        • Intravenous
      • By Application:
        • Canine Lymphoma
        • Osteosarcoma (OSA)
        • Mast Cell Cancer
        • Melanoma
        • Multiple Myeloma
      • By Distribution Channel:
        • Hospital Pharmacies
        • Government Agencies
        • Retail Pharmacies
    • Middle East
      • By Country/Region:
        • GCC
        • Israel
        • Rest of Middle East
      • By Animal Type:
        • Companion Animal
          • Equine
          • Canine
          • Feline
        • Livestock Animal
      • By Therapy Type:
        • Chemotherapy
        • Combination Therapy
        • Immunotherapy
        • Targeted Therapy
      • By Mode of Administration:
        • Oral
        • Intravenous
      • By Application:
        • Canine Lymphoma
        • Osteosarcoma (OSA)
        • Mast Cell Cancer
        • Melanoma
        • Multiple Myeloma
      • By Distribution Channel:
        • Hospital Pharmacies
        • Government Agencies
        • Retail Pharmacies
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Animal Type:
        • Companion Animal
          • Equine
          • Canine
          • Feline
        • Livestock Animal
      • By Therapy Type:
        • Chemotherapy
        • Combination Therapy
        • Immunotherapy
        • Targeted Therapy
      • By Mode of Administration:
        • Oral
        • Intravenous
      • By Application:
        • Canine Lymphoma
        • Osteosarcoma (OSA)
        • Mast Cell Cancer
        • Melanoma
        • Multiple Myeloma
      • By Distribution Channel:
        • Hospital Pharmacies
        • Government Agencies
        • Retail Pharmacies
  • Company Profiles
    • Zoetis Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Elanco
    • AB Science
    • Boehringer Ingelheim International GmbH
    • Zenoaq
    • VetDC
    • Morphogenesis, Inc.
    • Karyopharm Therapeutics, Inc.
    • Regeneus Ltd.
    • AdvaVet, Inc.
    • Rhizen Pharmaceutical SA

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Animal Type
      • Market Snippet, By Therapy Type
      • Market Snippet, By Mode of Administration 
      • Market Snippet, By Application
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Initiatives for Prevention and Control of Veterinary Oncology
    • Radiation Therapy
    • Market Trends
    • Product Recall
    • Epidemiology
    • Key Developments 
    • Cancers in Cats
    • Cancers in Dogs
    • Chemotherapy Agents Commonly used in Veterinary Medicine  
    • Regulatory Scenario
    • Veterinary Medicines: Patent Information
    • Veterinary Cancer: Awareness Campaign
    • Mergers and Acquisitions
    • PEST Analysis
  4.  Global Veterinary Oncology Market, By Animal Type, 2019 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Companion Animal
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
        • Equine
          •  Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
        • Canine
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
        • Feline
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
    • Livestock Animal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
  5. Global Veterinary Oncology Market, By Therapy Type 2019 – 2026, (US$ Million)
            • Introduction
              • Market Share Analysis, 2018 and 2026 (%)
              • Y-o-Y Growth Analysis, 2017 – 2026
              • Segment Trends
            • Chemotherapy
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
            • Combination Therapy
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
            • Immunotherapy
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
            • Targeted Therapy
              • Introduction
              • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
  6. Global Veterinary Oncology Market, By Mode of Administration  , 2019 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Oral
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
    • Intravenous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
  7. Global Veterinary Oncology Market, By Application, 2019 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Canine Lymphoma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
    • Osteosarcoma (OSA)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
    • Mast Cell Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
    • Melanoma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
    • Multiple Myeloma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
  8. Global Veterinary Oncology Market, By Distribution Channel, 2016 – 2026 (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
    • Government Agencies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
    • Retail Pharmacies
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
  9. Global Veterinary Oncology Market, By Region, 2016 – 2026 (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Animal Type, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Therapy Type, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Mode of Administration, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2019 – 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Animal Type, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Therapy Type, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Mode of Administration, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2019 – 2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Animal Type, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Therapy Type, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Mode of Administration, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2019 – 2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Animal Type, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Therapy Type, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Mode of Administration, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2019 – 2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Animal Type, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Therapy Type, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Mode of Administration, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2019 – 2026, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Animal Type, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Therapy Type, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Mode of Administration, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2019 – 2026, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2019 – 2026, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  10. Competitive Landscape
    • Company Profiles
      • Zoetis Inc.*
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Elanco
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • AB Science
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Boehringer Ingelheim International GmbH
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Zenoaq
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • VetDC
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Morphogenesis, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Karyopharm Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Regeneus Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • AdvaVet, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Rhizen Pharmaceutical SA
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  11. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 47 market data tables and 45 figures on "Veterinary Oncology Market” - Global forecast to 2026”

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.